Issue - meetings

The Board resolved:-

(i)             to approve the ADP investments as detailed at 3.18 of the report;

(ii)           to note that a seminar on the topic was to be planned for September 2022; and

(iii)          to note that Members were welcome to contact the Strategic Lead - Alcohol and Drugs, with any questions or topics for the seminar.

The Board had before it a report updating the Integration Joint Board (IJB) on the programme of investment and work being undertaken by Aberdeen City Alcohol & Drug Partnership (ADP) in relation to funding made available via the Scottish Government’s National Mission to reduce drug related harm.

Simon Rayner - Strategic Lead, Alcohol and Drugs, spoke to the report and responded to questions from Members.

The report recommended:-

that the Board:

(a)           approve the ADP investments as detailed at 3.13 of the report;

(b)           make the directions as attached within Appendix A of the report and instruct the Chief Officer to issue the direction to NHS Grampian (NHSG) to deliver the ADP plans outlined in A, B, D, E, F, G, H, I, J, L and M as stated at 2.1.1 of the report; and

(c)           make the directions as attached within Appendix B of the report and instruct the Chief Officer to issue the direction to Aberdeen City Council (ACC) to deliver the ADP plans outlined in B, C, G, I and L.

The Board resolved:-

(i)             to note that a seminar on the topic was to be planned for September 2022;

(ii)           to note that Members were welcome to contact the Strategic Lead - Alcohol and Drugs, with any questions or topics for the seminar; and

(iii)          to otherwise approve the recommendations.